Midi Health Review
Midi Health is a telehealth platform founded in 2021 and based in San Francisco, specializing in perimenopause and menopause care for women 40 and older. Its clinical model is built around menopause-trained practitioners — including nurse practitioners and physicians with specific expertise in midlife women's health — who conduct video consultations rather than relying primarily on asynchronous messaging. Midi has positioned itself as evidence-based and insurance-compatible, which distinguishes
Quick Facts
| Starting Price | Contact provider |
| Medications | 2 peptides |
| Consultation | Hybrid |
| Shipping | 3-5 business days |
| Lab Testing | Not included |
| Prescriber | Licensed healthcare providers evaluate patients and prescribe based on clinical eligibility. |
Midi Health offers 2 peptides for GLP-1 therapy. Midi Health is a telehealth platform founded in 2021 and based in San Francisco, specializing in perimenopause and menopause care for women 40 and older. Its clinical model is built around menopause-trained practitioners — including nurse practitioners and physicians with specific expertise in midlife women's health — who conduct video consultations rather than relying primarily on asynchronous messaging. Midi has positioned itself as evidence-based and insurance-compatible, which distinguishes
Pros & Cons
What We Like
- Video-first model provides more clinical depth than async-only platforms
- Insurance accepted for some services
- Clinicians trained specifically in menopause and perimenopause, not general practitioners covering the topic incidentally
- Metabolic and hormonal co-management reflects clinically appropriate care for the 40+ demographic
- Evidence-based positioning means less reliance on marketing-driven prescribing patterns
Watch Out For
- Video appointment model requires scheduling, which is less flexible than asynchronous platforms
- Insurance coverage is variable
- GLP-1 offering is secondary to the hormonal health core
- Newer platform (founded 2021) with less established track record than older telehealth providers
- Compounded GLP-1 availability is subject to FDA enforcement changes; branded options carry higher list prices
Pricing Breakdown
Pricing not yet verified for Midi Health. Visit their site for current pricing →
Medications Offered
2 peptides available through Midi Health.
Semaglutide
weight-loss · Subcutaneous injection (weekly)
A GLP-1 receptor agonist originally developed for type 2 diabetes, now widely prescribed for weight management. Reduces appetite and slows gastric emptying.
Tirzepatide
weight-loss · Subcutaneous injection (weekly)
A dual GIP/GLP-1 receptor agonist for weight management and type 2 diabetes. Clinical trials show significant weight reduction, often exceeding semaglutide results.
Considering Midi Health?
Request a free, no-obligation consultation. We'll share your details with Midi Healthand they'll reach out within 1–2 business days.
Midi Health — Full Profile
Midi Health — Provider Profile
Overview
Midi Health is a telehealth platform founded in 2021 and based in San Francisco, specializing in perimenopause and menopause care for women 40 and older. Its clinical model is built around menopause-trained practitioners — including nurse practitioners and physicians with specific expertise in midlife women's health — who conduct video consultations rather than relying primarily on asynchronous messaging. Midi has positioned itself as evidence-based and insurance-compatible, which distinguishes it from most cash-pay-only women's health telehealth platforms.
Alongside its core hormonal health services, Midi offers GLP-1 prescriptions for weight management, framed within a metabolic and hormonal clinical context. This framing reflects sound clinical reasoning: during perimenopause, estrogen decline reduces insulin sensitivity, promotes visceral fat accumulation, and alters the function of appetite-regulating hormones including leptin and GLP-1 itself. Prescribing a GLP-1 medication without accounting for these hormonal drivers risks treating a symptom of a broader metabolic shift rather than the underlying physiology. Midi's practitioners are trained to assess this intersection, which is a meaningful clinical advantage over generic telehealth GLP-1 services for this age group.
As of April 2026, the regulatory environment for GLP-1 prescribing has tightened. The FDA removed compounded semaglutide's shortage exemption in February 2025, ending the legal basis for most compounding pharmacy production of semaglutide at scale. Patients seeking GLP-1 treatment through Midi should ask specifically which formulations are currently available and whether insurance coverage applies to their situation. Verify all current medication availability and pricing at joinmidi.com.
Medications Offered
- GLP-1 medications for weight management (specific formulations — verify at joinmidi.com at time of consultation)
- Hormone replacement therapy: estradiol, progesterone, and related hormonal support (core service)
- Thyroid management and other metabolic health services (select cases)
Pricing
| Service | Cost | What's Included |
|---|---|---|
| Video consultation (insured) | Copay (varies by plan) | Consultation with menopause specialist |
| Video consultation (cash-pay) | Varies | Consultation; verify at joinmidi.com |
| GLP-1 medications | Copay or out-of-pocket; varies | Prescription management |
| HRT | Copay or out-of-pocket; varies | Ongoing hormone therapy management |
Midi accepts insurance for some services, which meaningfully affects total out-of-pocket cost. Cash-pay rates and current insurance participation should be verified directly at joinmidi.com, as coverage agreements change. Medication costs depend on specific drug, dosage, and insurance formulary.
States Served
Midi Health operates across multiple US states, with ongoing expansion. The platform's insurance-based model means availability may be more selective than cash-pay-only platforms. Confirm whether Midi operates in your state and whether your insurance is in-network at joinmidi.com before booking.
Insurance
- Midi accepts insurance for consultations, with coverage depending on your specific plan and state
- Some commercial insurance plans cover GLP-1 medications for patients meeting clinical criteria (BMI, comorbidities)
- FSA and HSA accounts are generally applicable to eligible medical expenses
- Patients should verify Midi's current insurance partnerships and in-network status before enrolling
Consultation Process
Model: Video consultations with menopause specialists
- Complete online intake covering hormonal symptoms, weight history, medical history, and current medications
- Schedule a video consultation with a Midi menopause specialist
- Clinician conducts a comprehensive evaluation covering hormonal and metabolic health
- Treatment plan developed — may include HRT, GLP-1 referral, or combination approach
- Prescriptions sent to pharmacy; follow-up appointments scheduled as needed
- Ongoing care management through the platform
Pros
- Video-first model provides more clinical depth than async-only platforms
- Insurance accepted for some services — reduces out-of-pocket cost compared to cash-pay competitors
- Clinicians trained specifically in menopause and perimenopause, not general practitioners covering the topic incidentally
- Metabolic and hormonal co-management reflects clinically appropriate care for the 40+ demographic
- Evidence-based positioning means less reliance on marketing-driven prescribing patterns
Cons
- Video appointment model requires scheduling, which is less flexible than asynchronous platforms
- Insurance coverage is variable — patients outside Midi's in-network footprint face full cash-pay costs
- GLP-1 offering is secondary to the hormonal health core — patients primarily seeking GLP-1 treatment may find more dedicated platforms elsewhere
- Newer platform (founded 2021) with less established track record than older telehealth providers
- Compounded GLP-1 availability is subject to FDA enforcement changes; branded options carry higher list prices
Best For
Midi Health is well-matched for women in perimenopause or menopause who want a video-based, clinician-led approach to midlife metabolic health — particularly those with insurance coverage that partially offsets the cost. If you are managing hormonal symptoms and metabolic weight changes simultaneously and want a provider trained to see the clinical connection between them, Midi offers a more comprehensive evaluation than most telehealth platforms. It is also a strong option for patients who prefer the clinical accountability of live video consultations over text-based asynchronous care.
Editorial Verdict
Midi Health addresses a genuine gap in telehealth: the intersection of menopause and metabolic health is clinically complex, and most platforms treat these as separate service lines requiring separate providers. Midi's video-first, insurance-compatible model positions it as a more clinically rigorous option than many cash-pay competitors in the women's health GLP-1 space.
The practical trade-offs are scheduling friction and insurance variability. Video appointments require coordination that asynchronous platforms do not, and insurance coverage — while available — is not guaranteed. Patients in states where Midi is not in-network, or with plans that exclude GLP-1 coverage, may find the costs add up comparably to cash-pay alternatives.
For women 40 and older who want evidence-based co-management of hormonal and metabolic health, with the option to use insurance, Midi is one of the more clinically sound options in the current telehealth landscape. It is not the right fit for patients seeking quick GLP-1 access or the lowest possible monthly cost — but for the patient who wants depth of clinical reasoning, it is worth the additional friction.
Related Content
Midi Health Review 2026: Menopause Telehealth, Insurance, Cost & Honest Assessment
Midi Health Review 2026: Menopause Telehealth, Insurance, Cost & Honest Assessment
Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026. Pricing and protocol data sourced from Midi Health's public communications, verified April 2026. We have no commercial relationship with this provider.
Midi Health is the strongest choice for insured patients seeking menopause telehealth care. It accepts PPO insurance and some Medicare Advantage plans — which can reduce visit costs to $0–$30 in copays — and it operates as a clinical practice with menopause-certified providers rather than as a subscription-based questionnaire service. The platform covers the full menopause symptom spectrum: HRT, non-hormonal hot flash treatments, mood support, sleep, bone health, and more. The trade-off is that self-pay pricing ($150–$250/visit) runs higher than the flat-rate models at Winona ($73–$199/month) and Alloy Women's Health (~$75/month for the patch protocol).
Midi Health practitioners have menopause-specific training that goes beyond standard OB/GYN board certification — the platform hires providers specifically for their menopause expertise, which is not universal in primary care or general telehealth.
Who Is Midi Health Best For?
Midi Health serves a specific patient profile. The platform's advantages over cash-pay competitors are most pronounced for a subset of patients.
Midi Health is a strong fit if you:
- Have PPO insurance and want menopause care that bills it — Midi is the only major telehealth menopause platform with broad in-network coverage
- Have complex or multiple symptoms — hot flashes, mood changes, sleep problems, vaginal dryness, bone concerns, weight changes — that benefit from one provider who knows your full picture
- Want live video consultation with your prescribing provider, not just async questionnaire review
- Need non-hormonal options: SSRIs or SNRIs for hot flashes and mood, fezolinetant (Veoza), sleep support, or bisphosphonates for bone density
- Are in perimenopause with variable symptoms that are harder to manage through a fixed protocol
- Cannot or choose not to take hormones and need clinical guidance on non-hormonal alternatives
Consider other options if you:
- Are cash-pay and want a predictable flat monthly rate — Alloy Women's Health (~$75/month) or Winona ($73–$199/month) are easier to budget
- Want to start quickly without scheduling a video appointment — Winona and Alloy accept async questionnaire intake
- Need GLP-1 prescriptions — Midi Health does not prescribe GLP-1 medications as of April 2026
- Are primarily seeking compounded combination HRT creams — Winona is the purpose-built option for that
- Live in a state where Midi Health is not yet licensed — state availability varies
See our best online HRT guide for a full comparison across platforms.
What Does Midi Health Offer?
Midi Health's clinical scope is the broadest of the three major menopause telehealth platforms — it covers the full midlife health picture, not just hormone replacement.
Hormone replacement therapy:
- Estradiol (oral tablets, transdermal patches, topical gels)
- Progesterone (micronized capsules)
- Vaginal estrogen (for local treatment of vaginal dryness and atrophy)
- Low-dose testosterone (off-label, for libido and energy)
- Both FDA-approved medications and, where clinically appropriate, compounded formulations
Non-hormonal menopause treatments:
- Fezolinetant (Veoza) — FDA-approved non-hormonal medication for moderate to severe hot flashes; an NK3 receptor antagonist; a meaningful option for women who cannot or choose not to take hormones
- SSRIs and SNRIs — specifically paroxetine (FDA-approved for hot flashes), venlafaxine, and escitalopram; prescribed off-label for hot flashes, mood, and anxiety in perimenopause and menopause
- Sleep support medications
- Bisphosphonates for bone density (osteoporosis prevention)
What Midi Health does not prescribe:
- GLP-1 medications (Ozempic, Wegovy, Zepbound, tirzepatide) — not part of Midi's service scope as of April 2026
- The platform is focused on menopause and midlife women's health; patients seeking GLP-1s for weight management should use a separate platform
The non-hormonal treatment breadth — particularly fezolinetant and evidence-based SSRIs/SNRIs — is a practical differentiator. Women with a history of breast cancer, clotting disorders, or other contraindications to HRT have real clinical alternatives at Midi rather than being told the platform cannot help them.
How Much Does Midi Health Cost?
Midi Health's pricing depends heavily on insurance status. Unlike Winona and Alloy, which charge flat subscription fees, Midi bills as a clinical practice.
Pricing last verified April 2026. We update pricing data monthly.
| Scenario | Approximate Cost | Notes |
|---|---|---|
| With PPO insurance (in-network) | $0–$30 copay per visit | Varies by plan; confirm in-network status |
| Self-pay | ~$150–$250 per visit | No subscription; per-visit billing |
| Medications (insurance) | Standard copay through pharmacy benefit | Depends on your plan's formulary |
| Medications (self-pay) | Retail pharmacy pricing + GoodRx | FDA-approved generics: ~$25–$50/month |
| Medicare Advantage | Some plans accepted | Confirm coverage before booking |
Pricing sourced from Midi Health public information and third-party references as of April 2026. Midi's website pricing pages were not publicly accessible at time of verification — confirm current rates directly before booking.
The insurance math: For a patient with PPO coverage where Midi is in-network, the annual cost of menopause care might be $0–$360 in copays plus pharmacy costs. The same care at Winona runs $876–$2,388/year; at Alloy ~$949/year ($49.95 consult + $75/month × 12). The insurance advantage is substantial for eligible patients.
The self-pay math: At $150–$250 per visit, Midi is the most expensive cash-pay option of the three. Two visits per year plus pharmacy costs can approach or exceed annual Alloy or Winona subscription costs. For cash-pay patients, Alloy or Winona offer more predictable flat pricing.
How Does Midi Health's Clinical Process Work?
Midi Health operates as a clinical telehealth practice, not a prescription-subscription service. The intake and follow-up structure is more involved than Winona or Alloy.
1. Intake and scheduling
Patients complete a medical history and symptom questionnaire, then schedule a video consultation with a Midi provider. The video visit is the standard entry point — not an async questionnaire reviewed by a physician afterward. This is a meaningful difference from Winona's and Alloy's primarily async models.
2. Video consultation with a menopause-certified provider
Midi staffs OBGYNs and nurse practitioners who have completed menopause-specific training. The consultation covers symptom history, medical history, contraindications, and treatment goals in real time. A provider can ask follow-up questions, which async platforms cannot. For patients with complex or ambiguous symptoms, this real-time exchange has clinical value.
3. Treatment plan and prescription
FDA-approved medications are the default. Compounded formulations are available when clinically appropriate. The treatment plan may include multiple elements — HRT alongside an SSRI for mood, or vaginal estrogen alongside systemic HRT for women with concurrent vaginal symptoms.
4. Ongoing care and follow-up
Midi is designed for ongoing care relationships, not one-time prescription access. Follow-up visits monitor symptom response, adjust doses, and add or remove medications as the clinical picture changes. This is appropriate for menopause — a multi-year transition that often requires protocol adjustments — but it requires ongoing engagement with the platform.
On bioidentical and compounded HRT: If Midi prescribes compounded formulations for your care, apply the same clinical context as with any compounding platform: compounded hormones are not FDA-approved as finished products, carry quality-control variables, and lack the large-trial safety data that applies to FDA-approved estradiol and progesterone. The clinical case for compounding is real in specific situations, but most patients benefit most from starting with FDA-approved options.
What Are the Pros and Cons of Midi Health?
Pros
- Insurance accepted — the primary cash-cost differentiator; visits may cost $0–$30 for insured patients
- Clinical scope — non-hormonal options (fezolinetant, SSRIs, sleep, bone) alongside HRT from one provider
- Live video consultations — real-time clinical interaction, not async questionnaire review
- Menopause-certified providers — menopause-specific training on prescriber staff
- Manages complex cases — better suited for patients with multiple symptoms or conditions than single-protocol platforms
Cons
- Self-pay pricing is high ($150–$250/visit) versus Winona and Alloy flat rates
- More process-intensive: scheduling a video appointment has more friction than async questionnaire intake
- Insurance routing introduces prior authorization risk and variable copay uncertainty — you may not know your cost before booking
- Does not prescribe GLP-1 medications
- State availability varies — not yet available in all US states
- Pricing transparency on the public website is limited — confirm costs before booking
How Does Midi Health Compare to Winona and Alloy?
| Midi Health | Alloy Women's Health | Winona | |
|---|---|---|---|
| Care model | Live video consultations | Async + video option | Async primarily |
| Insurance | PPO + some Medicare Advantage | Cash-pay only | Cash-pay only |
| Typical monthly cost (insured) | $0–$30 copay | N/A | N/A |
| Typical monthly cost (cash-pay) | $150–$250/visit | ~$75/month | $73–$199/month |
| HRT type | FDA-approved + compounded | FDA-approved primary | Compounded only |
| Non-hormonal options | Fezolinetant, SSRIs, bisphosphonates | Fezolinetant | None |
| GLP-1 prescriptions | No | Yes | No |
| Practitioner credentials | Menopause-trained OBGYNs and NPs | NCMP-certified physicians | Licensed physicians |
| Labs required | Typically yes | Recommended | Optional |
The decision framework:
- PPO insured → Check Midi Health's in-network status first. If covered, it is likely the lowest-cost option with the strongest clinical breadth.
- Cash-pay, want FDA-approved medications → Alloy Women's Health at ~$75/month with NCMP-certified physicians.
- Cash-pay, want compounded BHRT → Winona at $73–$199/month with no upfront consultation fee.
For a direct head-to-head on Winona and Alloy, see our Winona vs Alloy comparison.
Is Midi Health Legit?
Yes. Midi Health is a legitimate telehealth clinical practice. It is not a supplement company or a subscription service that happens to offer prescription access — it operates as a medical practice that bills insurance, employs licensed physicians and nurse practitioners, and follows standard clinical prescribing guidelines.
The questions patients should ask when evaluating Midi are practical rather than about legitimacy: Is Midi in-network with my insurance? Is Midi available in my state? Am I comfortable with video visits rather than async interactions? Is the self-pay rate reasonable if my insurance doesn't cover it fully?
For editorial transparency: this review was produced independently. We have no commercial relationship with Midi Health, Winona, or Alloy Women's Health. Read more about our editorial process and independence.
Frequently Asked Questions
Is Midi Health legit?
Yes. Midi Health is a legitimate telehealth clinical practice staffed by OBGYNs and menopause-certified practitioners. It bills PPO insurance, prescribes FDA-approved medications, and operates under standard telehealth prescribing regulations.
Does Midi Health accept insurance?
Yes. Midi Health accepts PPO insurance and some Medicare Advantage plans. Visit copays with in-network coverage typically run $0–$30. Medication costs depend on your pharmacy benefit. Always confirm that Midi is in-network with your specific plan before booking.
How much does Midi Health cost?
With PPO insurance (in-network), approximately $0–$30 per visit. Self-pay is approximately $150–$250 per visit. Medications are billed through pharmacy benefits with insurance or at GoodRx retail rates without. There is no subscription fee separate from visit costs.
Is Midi Health good for perimenopause?
Midi Health is well-suited for perimenopause. The variable, multi-symptom nature of perimenopause benefits from a provider who can assess the full picture across hormones, mood, sleep, and bone health. Live video consultations allow real-time clinical conversation that questionnaire-only platforms cannot replicate.
How does Midi Health compare to Alloy Women's Health?
Midi Health accepts insurance and has broader clinical scope; Alloy Women's Health is cash-pay only but charges a transparent ~$75/month for the estradiol patch plus progesterone protocol with NCMP-credentialed physicians. Insured patients generally do better at Midi. Cash-pay patients who want a predictable monthly rate and menopause-specialist physicians often find Alloy's model simpler. See our best online HRT guide for the full comparison.
For online HRT cost comparisons across platforms, see our online HRT cost guide. For a detailed comparison of the two leading cash-pay platforms, see our Winona vs Alloy comparison. For our full review of Alloy Women's Health, see our Alloy review. For our full Winona review, see our Winona review.
Patient Reviews
No patient reviews on Telehealth Ally yet. Be the first to review Midi Health
Used Midi Health? Help others decide.
Leave your email and we'll send you a short, 3-minute review form. Your honest experience helps the next patient make a better choice.
We'll only email you once about this review. No spam. Write a review now
How Midi Health Compares
See how Midi Health stacks up against other GLP-1 providers.
Provider Comparisons
Medication Comparisons
Ready to explore Midi Health?
Based on our independent review, Midi Health offers 2 peptides for GLP-1 therapy. Request a free consultation or visit their site to get started.
Telehealth Ally may receive compensation when you request a consultation. This does not affect our rankings or reviews.
Get weekly GLP-1 pricing updates
We track prices so you don't have to.
No spam. Unsubscribe anytime.
How We Review Providers
Our editorial team independently evaluates every telehealth provider based on pricing transparency, medication availability, clinical protocols, and patient experience. We verify pricing data weekly and update reviews when providers change their offerings. Revenue never influences our rankings or recommendations.
Read our editorial standards →